- Reliq Health Technologies (RHT) announced that it has signed five new contracts with physician practices and home health agencies in several U.S. states
- The company’s iUGO Care platform is being used in a new clinical trial
- The contracts will add over 2,500 patients to Reliq’s platform this year, generating an average revenue of $50 per patient per month
- Reliq Health Technologies specializes in developing Software-as-a-Service (SaaS) solutions for remote patient monitoring
- Reliq Health Technologies Inc. (RHT) opened trading at C$0.50 per share
Reliq Health Technologies (RHT) announced that it has signed five new contracts with physician practices and home health agencies.
These contracts are expected to add over 2,500 patients in California, Texas, Michigan and Maryland to Reliq’s platform this year.
The company also announced that its iUGO Care platform is being used in a new clinical trial.
Dr. Lisa Crossley, CEO at Reliq Health Technologies, commented on the news.
“We are very pleased to be going live in another clinical trial, this one for diabetics using both standard glucometers and continuous blood glucose monitors. The ability of the iUGO Care platform to connect to a wide range of connected devices is a key competitive advantage for Reliq in the virtual care and clinical trials markets. The diabetes clinical trial will also be utilizing iUGO Voice, Reliq’s interactive voice recognition technology, to facilitate patient follow up. We are also excited to announce that we have signed five new contracts with healthcare providers in California, Texas, Maryland and Michigan. These clients are expected to add over 2,500 patients to our platform in 2022, at an average revenue of $50 per patient per month at 75 per cent gross margin.”
Reliq Health Technologies specializes in developing Software-as-a-Service (SaaS) solutions for remote patient monitoring, telemedicine, and care collaboration. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits.
Reliq Health Technologies Inc. (RHT) opened trading at C$0.50 per share.
